Abstract
Objectives
The aim of this study was to compare quality of life and symptoms between breast cancer survivors who have developed and undergone treatment for chronic lymphedema with those who have not developed lymphedema.
Patients and methods
The cross-sectional, mixed-methods design included 64 breast cancer survivors with lymphedema and 64 breast cancer survivors without lymphedema. Variables assessed quantitatively included sociodemographic information, medical data, body mass index (BMI), arm extracellular fluid volume, quality of life (QOL), and physical and emotional symptoms. For the qualitative component, individuals with lymphedema responded in writing to the question: During the past week what other difficulties have you experienced because of your lymphedema?
Results
Compared with those without lymphedema, breast cancer survivors with lymphedema reported poorer QOL. A symptom cluster that included alteration in limb sensation, loss of confidence in body, decreased physical activity, fatigue, and psychological distress was identified. Perception of limb size influenced the cumulative symptom experience more than objective arm volume. Qualitative data revealed multiple QOL, physical health, and psychological concerns. BMI correlated with multiple outcomes.
Conclusions
Findings suggest that current lymphedema treatments, although beneficial, may not provide complete relief of symptoms associated with lymphedema and complementary interventions are needed. The poorer QOL in breast cancer survivors with lymphedema may relate to the presence of an untreated symptom cluster.
This is a preview of subscription content,
to check access.References
Armer J, Porock C (2001) Self reported fatigue in women with lymphedema. Lymph Link 13:1–4
Carpenter JS, Andrykowski MA, Wilson J et al (1998) Psychometrics for two short forms of the center for epidemiologic studies depression scale. Issues Ment Health Nurs 19:481–494
Casley-Smith JR, Morgan RG, Piller NB (1993) Treatment of lymphedema of the arms and legs with 5, 6-benzo-[alpha]-pyrone. N Engl J Med 329:1158–1163
Cella D (1997) FACIT manual: manual of the functional assessment of chronic illness therapy (FACIT) measurement system, version 4. Evanston Northwestern Healthcare & Northwestern University, Chicago
Cornish BH, Bunce IH, Ward LC et al (1996) Bioelectric impedance for monitoring the effect of lymphoedema treatment programs. Breast Cancer Res Treat 38:169–176
Coster S, Poole K, Fallowfield LJ (2001) The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat 68:73–282
Curran SL, Androykowski MA, Studts JL (1995) Short form of the Profiles of Mood State (POMS-SF): psychometric information. Psychol Assess 7:80–83
Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28:465–470
Foldi E, Foldi M, Clodius L (1989) The lymphedema chaos: a lancet. Ann Plast Surg 22:505–515
Foldi M, Foldi E (2003) Physiology and pathophysiology of the lymphatic system. In: Foldi M, Foldi E, Kubik S (eds) Textbook of lymphology for physicians and lymphedema therapists. Urban & Fischer, Munich, pp 195–230
Impedimed (2002) Lymphometer: the new tool in monitoring lymphedema. Mansfield, Australia
International Society of Lymphology (2003) The diagnosis and treatment of peripheral lymphedema: consensus document of the International Society of Lymphology. Lymphology 36:84–91
Johansson K, Albertsson M, Ingvar C et al (1999) Effects of compression bandaging with or without manual lymph drainage treatment in patients with postoperative arm lymphedema. Lymphology 32:103–110
Johansson K, Lie E, Ekdahl C (1998) A randomized study comparing manual lymph drainage with sequential pneumatic compression for treatment of postoperative arm lymphedema. Lymphology 31:56–64
Johansson K, Ohlsson K, Ingvar C et al (2002) Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology 35:59–71
Kohout FJ, Berkmen LF, Evans DA et al (1993) Two shorter forms of the CES-D depression symptoms index. J Aging Health 5:179–193
Launois L, Alliot F (2000) Quality of life scale in upper limb lymphedema: a validation study. Lymphology 33(Suppl):266–274
Logan VB (1995) Incidence and prevalence of lymphoedema: a literature review. J Clin Nurs 4:213–219
Mirolo BR, Bunce IH, Chapman M et al (1995) Psychosocial benefits of postmastectomy therapy. Cancer Nurs 18:197–205
Passik SD, Newman M, Brennan M et al (1993) Psychiatric consultation for women undergoing rehabilitation for upper-extremity lymphedema following breast cancer treatment. J Pain Symptom Manage 8:226–233
Petrek JA, Heelan MC (1998) Incidence of breast carcinoma-related lymphedema. Cancer 83:2776–2780
Ridner SH (2002) Breast cancer lymphedema: pathophysiology and risk reduction guidelines. Oncol Nurs Forum 29:1285–1291
Say CC, Donegan W (1974) A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet 138:370–376
Shacham S (1983) A shortened version of the profile of mood states. J Pers Assess 47:305–306
Ward LC, Bunce IH, Cornish BH et al (1992) Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients. Eur J Clin Investig 22:751–754
Werner RS, McCormick B, Petrek J et al (1991) Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 180:177–184
Woods M, Tobin M, Mortimer P (1995) The psychosocial morbidity of breast cancer patients with lymphoedema. Cancer Nurs 18:467–471
Acknowledgements
This research was funded by National Research Service Award 1 F31 NR07854-02, Sigma Theta Tau Iota Chapter grant, and Vanderbilt University Dissertation Enhancement Award.
This paper was presented in part at the 29th Oncology Nursing Society Congress, 29 April 2004, Anaheim, CA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ridner, S.H. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer 13, 904–911 (2005). https://doi.org/10.1007/s00520-005-0810-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-005-0810-y